Cetera Investment Advisers Adma Biologics, Inc. Transaction History
Cetera Investment Advisers
- $44.2 Billion
- Q3 2024
A detailed history of Cetera Investment Advisers transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Cetera Investment Advisers holds 55,927 shares of ADMA stock, worth $947,962. This represents 0.0% of its overall portfolio holdings.
Number of Shares
55,927
Previous 42,153
32.68%
Holding current value
$947,962
Previous $471,000
137.15%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding ADMA
# of Institutions
323Shares Held
190MCall Options Held
917KPut Options Held
91.6K-
Black Rock Inc. New York, NY18.6MShares$316 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.1MShares$307 Million0.01% of portfolio
-
State Street Corp Boston, MA13MShares$220 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA12.6MShares$214 Million0.05% of portfolio
-
Morgan Stanley New York, NY8.6MShares$146 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3.33B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...